Puxeddu E - Search Results

1

Role of exosomes in exacerbations of asthma and COPD: a systematic review.

Laitano R, Calzetta L, Motta E, Puxeddu E, Rogliani P. Laitano R, et al. Among authors: puxeddu e. Front Mol Biosci. 2024 Jun 18;11:1356328. doi: 10.3389/fmolb.2024.1356328. eCollection 2024. Front Mol Biosci. 2024. PMID: 38957448 Free PMC article. Review.

2

The prevalence of asthma and COPD in Italy: a practice-based study.

Cazzola M, Puxeddu E, Bettoncelli G, Novelli L, Segreti A, Cricelli C, Calzetta L. Cazzola M, et al. Among authors: puxeddu e. Respir Med. 2011 Mar;105(3):386-91. doi: 10.1016/j.rmed.2010.09.022. Epub 2010 Oct 15. Respir Med. 2011. PMID: 20951017 Free article.

3

Effect of an additional dose of indacaterol in COPD patients under regular treatment with indacaterol.

Cazzola M, Segreti A, Stirpe E, Puxeddu E, Ora J, Rogliani P, Matera MG. Cazzola M, et al. Among authors: puxeddu e. Respir Med. 2013 Jan;107(1):107-11. doi: 10.1016/j.rmed.2012.09.022. Epub 2012 Oct 18. Respir Med. 2013. PMID: 23083839 Free article. Clinical Trial.

4

A 6MWT index to predict O2 flow correcting exercise induced SpO2 desaturation in ILD.

Ora J, Calzetta L, Pezzuto G, Senis L, Paone G, Mari A, Portalone S, Rogliani P, Puxeddu E, Saltini C. Ora J, et al. Among authors: puxeddu e. Respir Med. 2013 Dec;107(12):2014-21. doi: 10.1016/j.rmed.2013.10.002. Epub 2013 Oct 10. Respir Med. 2013. PMID: 24161677 Free article.

5

Searching for the synergistic effect between aclidinium and formoterol: From bench to bedside.

Cazzola M, Calzetta L, Ora J, Puxeddu E, Rogliani P, Matera MG. Cazzola M, et al. Among authors: puxeddu e. Respir Med. 2015 Oct;109(10):1305-11. doi: 10.1016/j.rmed.2015.08.005. Epub 2015 Aug 13. Respir Med. 2015. PMID: 26303336 Free article. Clinical Trial.

6

Interaction between corticosteroids and muscarinic antagonists in human airways.

Cazzola M, Calzetta L, Rogliani P, Puxeddu E, Facciolo F, Matera MG. Cazzola M, et al. Among authors: puxeddu e. Pulm Pharmacol Ther. 2016 Feb;36:1-9. doi: 10.1016/j.pupt.2015.11.004. Epub 2015 Nov 30. Pulm Pharmacol Ther. 2016. PMID: 26656790

7

Olodaterol + tiotropium bromide for the treatment of COPD.

Calzetta L, Ciaprini C, Puxeddu E, Cazzola M. Calzetta L, et al. Among authors: puxeddu e. Expert Rev Respir Med. 2016 Apr;10(4):379-386. doi: 10.1586/17476348.2016.1156538. Epub 2016 Mar 22. Expert Rev Respir Med. 2016. PMID: 26894830

8

An unusual outbreak of nontuberculous mycobacteria in hospital respiratory wards: Association with nontuberculous mycobacterial colonization of hospital water supply network.

D'Antonio S, Rogliani P, Paone G, Altieri A, Alma MG, Cazzola M, Puxeddu E. D'Antonio S, et al. Among authors: puxeddu e. Int J Mycobacteriol. 2016 Jun;5(2):244-7. doi: 10.1016/j.ijmyco.2016.04.001. Epub 2016 May 6. Int J Mycobacteriol. 2016. PMID: 27242241 Free article.

9

Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells.

Cazzola M, Calzetta L, Puxeddu E, Ora J, Facciolo F, Rogliani P, Matera MG. Cazzola M, et al. Among authors: puxeddu e. Respir Res. 2016 Jun 13;17(1):70. doi: 10.1186/s12931-016-0386-8. Respir Res. 2016. PMID: 27296533 Free PMC article.

10

Onset of action of budesonide/formoterol Spiromax(®) compared with budesonide/formoterol Turbuhaler(®) in patients with COPD.

Cazzola M, Ora J, Di Paolo A, Puxeddu E, Calzetta L, Rogliani P. Cazzola M, et al. Among authors: puxeddu e. Pulm Pharmacol Ther. 2016 Aug;39:48-53. doi: 10.1016/j.pupt.2016.06.006. Epub 2016 Jun 22. Pulm Pharmacol Ther. 2016. PMID: 27344046 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

178 results

Search Page

Filters